Nom du produit:2-Cyclobutyl-10-methyl-3-phenylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione

IUPAC Name:2-cyclobutyl-10-methyl-3-phenyl-3H,4H,5H,10H-pyrimido[4,5-b]quinoline-4,5-dione

CAS:1613509-49-1
Formule moléculaire:C22H19N3O2
Pureté:95%+
Numéro de catalogue:CM1031942
Poids moléculaire:357.41

Unité d'emballage Stock disponible Prix($) Quantité
CM1031942-25mg in stock ȌƋȌ
CM1031942-100mg in stock DzɐȌ
CM1031942-250mg in stock Ƌȷɐȷ
CM1031942-1g in stock ȌƤȷȷ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1613509-49-1
Formule moléculaire:C22H19N3O2
Point de fusion:-
Code SMILES:CN1C2=C(C=CC=C2)C(=O)C2=C1N=C(C1CCC1)N(C1=CC=CC=C1)C2=O
Densité:
Numéro de catalogue:CM1031942
Poids moléculaire:357.41
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.